No major side-effects found: ICMR defends HCQ's use after WHO halts trials
Image Credit: shortpedia
Hours after WHO suspended all ongoing trials of anti-malaria drug Hydroxychloroquine over safety concerns, the Indian Council of Medical Research (ICMR) has defended its use. The apex health body, which has been leading India's fight against coronavirus, has said that the drug has 'no major side-effects' and its use should be continued. The only side-effects were nausea and occasional palpitations, per ICMR.